Tempus AI (NASDAQ:TEM) Lowered to “Hold” Rating by Stifel Nicolaus

Stifel Nicolaus lowered shares of Tempus AI (NASDAQ:TEM) from a buy rating to a hold rating in a research note published on Monday morning, MarketBeat.com reports. Stifel Nicolaus currently has $65.00 price objective on the stock, up from their previous price objective of $45.00.

TEM has been the subject of a number of other research reports. JPMorgan Chase & Co. raised their target price on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Bank of America cut Tempus AI from a “buy” rating to a “neutral” rating and increased their target price for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Piper Sandler began coverage on shares of Tempus AI in a research report on Monday, August 12th. They set a “neutral” rating and a $40.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $54.22.

Tempus AI Stock Down 16.8 %

NASDAQ:TEM opened at $56.63 on Monday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock has a 50-day simple moving average of $51.21. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. bought a new stake in Tempus AI in the 3rd quarter worth approximately $30,000. Vestor Capital LLC bought a new stake in shares of Tempus AI in the third quarter worth $153,000. The Manufacturers Life Insurance Company increased its position in Tempus AI by 10.2% during the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock valued at $1,686,000 after acquiring an additional 2,765 shares during the last quarter. Sandia Investment Management LP bought a new position in Tempus AI in the second quarter valued at about $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI in the 3rd quarter worth approximately $258,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.